SALES INTELLIGENCE FOR LIFE SCIENCES & MEDICAL DEVICE

SELL MORE.

WE DO THE REST

3X
THE SELLING
WE'LL DO
THE REST
Prospecting
+124 NEW CONTACTS
OUTREACH SENT
1X
Follow-up
+86 IN PROGRESS
SENT
OPENED
REPLIED
MEETING
Re-engagement
+52 REACTIVATED
BACK IN PIPELINE

THE PROBLEM

72% of a rep’s week isn’t selling.

Salespeople spend 28% of their time actually selling. We read every conversation the company has, do the other 72%, and hand the rep the next move already written. Same team, three times the selling.

OLD WAY
NEW WAY
28%
SELLING
mostly admin
SAME TEAM
RESEARCH
FOLLOW-UP
CRM ADMIN
PROSPECTING SUPPORT
HANDLED
RESEARCH ✓
FOLLOW-UP ✓
CRM ADMIN ✓
PROSPECTING SUPPORT ✓
3X THE SELLING
WE'LL DO THE REST.
DRAG TO SEE THE NEW WAY

Salesforce State of Sales, 7,775 sales professionals across 38 countries. 28% to 90% is 3.2x, stated as 3x.

THE BRIDGE WE NEED

THE PRODUCT WORKS. DELIVERY WORKS.

When the founder is in the room with the right company, it closes. The constraint is getting in front of them.

What is missing is a channel salesperson bringing qualified life sciences and medical device organisations to the table, so the founder can do what he does best, get them excited and close, then hand it to development and delivery.

This is a bridge over a sales problem, not a product problem, which is why the right investor matters more than the cheque.

WHO WE SELL TO

Life sciences and medical device sales organisations and divisions

SoftWave is the anchor client and the reason we start here: we know how these teams sell, how referral and practitioner networks behave, and where their deals stall. The platform works anywhere conversations can be recorded, but a vertical with a reference customer sells faster than a horizontal with none.

ANCHOR CLIENT
SoftWave
Life Sciences
Medical Device
Sales Organizations
Divisions
Referral Networks
Practitioner Networks

Traction

01
Live
Working product with a paying anchor client.
Profitable on a cash basis today.
02
$0M
Closed revenue influenced on the platform to date.
03
0%
Logo retention. No customer has ever churned.

3X in ninety days.

DAY 0 BASELINE
0%
Measured in the assessment, before anything is signed
DAY 30 CONNECT
0%
Calls, email, CRM and campaigns wired in. Research, recap and follow up come off the rep
DAY 60 CALIBRATE
0%
Tuned to your own won and lost outcomes. Pipeline coverage and prioritisation run themselves
DAY 90 COMPOUND
FINAL
0%+
3x
Oversight removed workflow by workflow, as each one earns it

Selling time is an activity measure and moves inside a quarter. Every engagement baselines it during assessment, before contract, so the improvement measured is against the customer’s own number rather than ours. Baseline of 28% from Salesforce State of Sales. Revenue effect follow behind it, because sales cycle length and revenue per lead cannot be read until a full cycle has turned over. The ninety day path is a deployment plan, not a forecast.

How it works.

WHAT WE MOVE, HOW WE ENGAGE, AND WHY WE ARE HARD TO REPLACE

What we move

Sales cycle length
0% shorter
After one full cycle. Deals stop waiting on a rep to work out the next step. Benchmarks report reductions up to 25%, so we commit under the ceiling.
Revenue per MQL
0% higher
After one full cycle. Every lead gets worked rather than the top of the list getting worked and the rest ageing out. Conversion lift is reported at 20% to 30%; we take the bottom.
Time to revenue
Measured per engagement
From first onboarding. New reps run on the organisation’s accumulated context instead of starting cold.

Targets, not results achieved. Benchmark ranges from Sopro, AI in B2B sales and marketing, December 2025. Selling time is the leading indicator and moves first; the revenue metrics trail it by a sales cycle.

How an engagement runs

Where it sits

ARCHITECTURE
01

ON TOP OF WHAT THEY ALREADY RUN

Salesforce, HubSpot, Dynamics and GoHighLevel hold the record. We read the conversations behind the record and say what to do next. Nothing gets ripped out.

02

SOLD THROUGH THE PLATFORMS

AWS Marketplace, and alongside the CRMs themselves. Buyers spend against cloud commitments they already hold, and the partner carries the introduction.

03

OUTSIDE THE MODEL

The IP is the context and the method, not the language model. We route to whichever model performs best, so every frontier release makes the product better at lower cost.

EXISTING STACK STAYS INTELLIGENCE ADDS CONTEXT BEST MODEL IS ROUTED

Why we are hard to replace

01
Encoded sales judgement
Decades of how deals are actually won, built into the IP as method rather than sitting in one person’s head.
02
Standard patterns
The same patterns solve the same problems across customers, so every engagement starts from a known shape.
03
Modular, reusable components
Solutions assemble from proven parts, which is what makes services profitable and deployment fast.
04
Elegant use of what exists
We compose mature enterprise stacks with fast moving AI rather than building either. When the tooling improves, we inherit it.
05
THE CONTEXT COMPOUNDS
Twelve months in, the system knows things a competitor starting today cannot buy.

THE RAISE

Capital, tied to progress

AT CLOSE
RELEASE 01
$400,000
$400,000 at close retires the legacy notes at return of capital, moves the founder off client delivery, and hires the first developer.
MONTH 6
RELEASE 02
$950,000
$950,000 at month six releases once the anchor client signs platform plus support and the product onboards without the founder.
MONTH 12
RELEASE 03
$10M
$10M at month twelve priced on recurring revenue and a signed channel partner.

18 Months Funded

Year five planning figures of 190 customers and $17.25M recurring assume a $90,000 average contract and no expansion revenue.

© 2026 Instantly Relevant. All rights reserved.